{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:10:34Z","timestamp":1770502234311,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,10,11]],"date-time":"2007-10-11T00:00:00Z","timestamp":1192060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2007,10,11]],"date-time":"2007-10-11T00:00:00Z","timestamp":1192060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00277-007-0382-7","type":"journal-article","created":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T15:52:51Z","timestamp":1192031571000},"page":"311-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting"],"prefix":"10.1007","volume":"87","author":[{"given":"Peter","family":"Kaskel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silja","family":"Tuschy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bannert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Glasmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Lipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Ullmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,11]]},"reference":[{"key":"382_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0163-4453(96)92700-0","volume":"33","author":"AH Groll","year":"1996","unstructured":"Groll AH, Shah PM, Mentzel C et al (1996) Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 33:23\u201332","journal-title":"J Infect"},{"key":"382_CR2","first-page":"183","volume":"7","author":"BJ Kullberg","year":"2002","unstructured":"Kullberg BJ, Oude Lashof AM (2002) Epidemiology of opportunistic invasive mycoses. Eur J Med Res 7:183\u2013191","journal-title":"Eur J Med Res"},{"key":"382_CR3","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1007\/s00277-003-0768-0","volume":"82","author":"M Ruhnke","year":"2003","unstructured":"Ruhnke M, B\u00f6hme A, Buchheidt D et al (2003) Diagnosis of invasive fungal infections in hematology and oncology. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82:S141\u2013S148","journal-title":"Ann Hematol"},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/sj.leu.2403317","volume":"18","author":"R Hehlmann","year":"2004","unstructured":"Hehlmann R, Berger U, Aul C et al (2004) The German competence network \u2018Acute and chronic leukemias\u2019. Leukemia 18:665\u2013669","journal-title":"Leukemia"},{"key":"382_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00001622-200107000-00004","volume":"13","author":"G Maschmeyer","year":"2001","unstructured":"Maschmeyer G (2001) Pneumonia in febrile neutropenic patients: radiologic diagnosis. Curr Opin Oncol 13:229\u2013235","journal-title":"Curr Opin Oncol"},{"key":"382_CR6","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1007\/s00330-004-2447-5","volume":"14","author":"U Zaspel","year":"2004","unstructured":"Zaspel U, Denning DW, Lemke AJ et al (2004) Diagnosis of IPA in HIV: the role of the chest X-ray and radiologist. Eur Radiol 14:2030\u20132037","journal-title":"Eur Radiol"},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMoa040446","volume":"351","author":"TJ Walsh","year":"2004","unstructured":"Walsh TJ, Teppler H, Donowitz GR et al (2004) Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 351:1391\u20131402","journal-title":"N Engl J Med"},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1086\/505969","volume":"43","author":"AJ Ullmann","year":"2006","unstructured":"Ullmann AJ, Sanz MA, Tramarin A et al (2006) Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries. Clin Infect Dis 43:e29\u2013e38","journal-title":"Clin Infect Dis"},{"key":"382_CR9","unstructured":"Drummond M, O\u2019Brien B, Stoddart G, Torrance G (eds) (1999) Methods for the economic evaluation of health care programmes, 2nd edn. Oxford University Press, Oxford New York Toronto"},{"key":"382_CR10","unstructured":"NN (2007) German DRG Calculation Scheme. www.g-drg.de\/cms\/index.php\/inek_site.de\/g_drg_system_2007\/fallpauschalen_katalog"},{"key":"382_CR11","unstructured":"NN (2002) Standard Tariff of the German Hospital Association (DKG-NT), 28th edn. Deutsche Krankenhausgesellschaft, Berlin"},{"key":"382_CR12","unstructured":"NN (2007) Lump compensation scheme for the German DRG System 2007 www.g-drg.de\/cms\/index.php\/inek_site.de\/g_drg_system_2007"},{"key":"382_CR13","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","volume":"318","author":"A Laupacis","year":"1988","unstructured":"Laupacis A, Sackett D, Roberts R (1988) An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 318:1728\u20131733","journal-title":"N Engl J Med"},{"key":"382_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0197-2456(00)00134-3","volume":"22","author":"R Bender","year":"2001","unstructured":"Bender R (2001) Calculating confidence intervals for the number needed to treat. Controlled Clinical Trials 22:102\u2013110","journal-title":"Controlled Clinical Trials"},{"key":"382_CR15","unstructured":"Sekretariat der Roten Liste GmbH (2007) Rote Liste Online www.roteliste.de"},{"key":"382_CR16","unstructured":"NN (2007) Harmonized consumer price index. Federal Statistical Office Germany www.destatis.de\/indicators\/e\/vpi120ae.htm"},{"key":"382_CR17","volume-title":"Cost-effectiveness, policy-making and regulation","author":"D Spiegelhalter","year":"2004","unstructured":"Spiegelhalter D, Abrams K, Myles J (2004) Cost-effectiveness, policy-making and regulation. Wiley, Hoboken, NJ, USA"},{"key":"382_CR18","unstructured":"Spiegelhalter D, Thomas A, Best N, Lunn D (2004) WinBUGS User Manual"},{"key":"382_CR19","doi-asserted-by":"crossref","DOI":"10.1002\/0470856289","volume-title":"Statistical analysis of cost-effectiveness data","author":"AR Willan","year":"2006","unstructured":"Willan AR, Briggs AH (2006) Statistical analysis of cost-effectiveness data. Wiley, Hoboken, NJ, USA"},{"key":"382_CR20","first-page":"176","volume":"26","author":"GR Barnes","year":"2001","unstructured":"Barnes GR, Cerrito PB (2001) The visualization of continuous data using PROC KDE and PROC capability. Proceedings of the 26th Annual SAS Users Group International Conference 26:176\u2013186","journal-title":"Proceedings of the 26th Annual SAS Users Group International Conference"},{"key":"382_CR21","volume-title":"SAS(R) for Monte Carlo studies: a guide for quantitative researchers","author":"X Fan","year":"2002","unstructured":"Fan X, Felsovalyi A, Sivo S, Keenan S (2002) SAS(R) for Monte Carlo studies: a guide for quantitative researchers. SAS Institute, Cary, NC, USA"},{"key":"382_CR22","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1086\/313498","volume":"29","author":"JR Wingard","year":"1999","unstructured":"Wingard JR, Kubilis P, Lee L et al (1999) Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis 29:1402\u20131407","journal-title":"Clin Infect Dis"},{"key":"382_CR23","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1056\/NEJM199903113401004","volume":"340","author":"TJ Walsh","year":"1999","unstructured":"Walsh TJ, Finberg RW, Arndt C et al (1999) Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 340:764\u2013771","journal-title":"N Engl J Med"},{"key":"382_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2146\/ajhp050521","volume":"64","author":"J Wingard","year":"2007","unstructured":"Wingard J, Leather H, Wood C, Gerth W, Lupinacci R, Berger M, Mansley E (2007) Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for febrile neutropenia. Am J Health Syst Pharm 64:637\u2013643","journal-title":"Am J Health Syst Pharm"},{"key":"382_CR25","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1086\/344468","volume":"35","author":"S Harbarth","year":"2002","unstructured":"Harbarth S, Burke JP, Lloyd JF et al (2002) Clinical and economic outcomes of conventional amphotericin B-associated nephrotoxicity. Clin Infect Dis 35:e120\u2013e127","journal-title":"Clin Infect Dis"},{"key":"382_CR26","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1600-0609.2007.00850.x","volume":"78","author":"K Bruynesteyn","year":"2007","unstructured":"Bruynesteyn K, Gant V, McKenzie C et al (2007) A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK. Eur J Haematol 78:532\u2013539","journal-title":"Eur J Haematol"},{"key":"382_CR27","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1055\/s-2004-832392","volume":"129","author":"A Billing","year":"2004","unstructured":"Billing A, Thalhammer M, Eissner HJ et al (2004) Economic aspects of intensive care medicine\u2013cost and reimbursement according to diagnosis related grouping. Zentralbl Chir 129:440\u2013446","journal-title":"Zentralbl Chir"},{"key":"382_CR28","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/sj.bmt.1704988","volume":"35","author":"V Mishra","year":"2005","unstructured":"Mishra V, Andresen S, Brinch L et al (2005) Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study. Bone Marrow Transplant 35:1149\u20131153","journal-title":"Bone Marrow Transplant"},{"key":"382_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/sj.bmt.1703310","volume":"28","author":"V Mishra","year":"2001","unstructured":"Mishra V, Vaaler S, Brinch L (2001) A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures. Bone Marrow Transplant 28:1111\u20131116","journal-title":"Bone Marrow Transplant"},{"key":"382_CR30","unstructured":"M\u00fcller M, Irps S, R\u00f6der N, DRG Research Group (2007) GDRG Grouping result for MDC17\/R60E\/PCCL4 [C92.00\/D70.3\/D69.59\/D.64.8\/Z51.1!, 34\u00a0days]. University of M\u00fcnster DRG Research Group http:\/\/drg.uni-muenster.de\/de\/webgroup\/m.webgroup.php"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0382-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-007-0382-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0382-7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0382-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T19:04:28Z","timestamp":1630436668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-007-0382-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,11]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1007\/s00277-007-0382-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,11]]},"assertion":[{"value":"30 April 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}